Dusigitumab
Lonigutamab
Istiratumab
Xentuzumab
Dalotuzumab
Ganitumab
Robatumumab
Teprotumumab
Cixutumumab
Figitumumab
Veligrotug
IGF-I (30-41) (TFA)
IGF-I (24-41)
IGF-I (24-41) (TFA)
Chimaphilin
Sorbic acid
AZ7550-d 5
AZ7550 hydrochloride
AZ7550 Mesylate
AZ7550